Routine consolidation of early stage primary bone lymphoma with radiation therapy does not improve outcomes.
作者信息
Hoffmann Marc S
机构信息
Division of Hematologic Malignancies and Cellular Therapeutics University of Kansas Cancer Center Kansas City, KS.
出版信息
Haematologica. 2024 May 1;109(5):1323-1324. doi: 10.3324/haematol.2023.284303.
Abstract
摘要
相似文献
1
Routine consolidation of early stage primary bone lymphoma with radiation therapy does not improve outcomes.
Haematologica. 2024 May 1;109(5):1323-1324. doi: 10.3324/haematol.2023.284303.
2
Primary lymphoma of bone--a retrospective study. Experience at the Northern Israel Oncology Center (1979-2000).
Oncology. 2003;64(4):322-7. doi: 10.1159/000070288.
3
Primary lymphoma of bone--survival and prognosis.
Korean J Intern Med. 2002 Sep;17(3):191-7. doi: 10.3904/kjim.2002.17.3.191.
4
A single-center retrospective analysis of outcome measures and consolidation strategies for relapsed and refractory primary CNS lymphoma.
J Neurooncol. 2021 Jan;151(2):193-200. doi: 10.1007/s11060-020-03648-9. Epub 2021 Jan 4.
5
6
Primary bone lymphoma: a new and detailed characterization of 28 patients in a single-institution study.
Jpn J Clin Oncol. 2007 Mar;37(3):216-23. doi: 10.1093/jjco/hym007.
7
Primary lymphoma of bone in children: analysis of treatment results with adriamycin, prednisone, Oncovin (APO), and local radiation therapy.
J Clin Oncol. 1986 Apr;4(4):496-501. doi: 10.1200/JCO.1986.4.4.496.
8
Primary lymphoma of bone in children.
J Clin Oncol. 1989 Sep;7(9):1275-80. doi: 10.1200/JCO.1989.7.9.1275.
9
A highly curable lymphoma occurs preferentially in the proximal tibia of young patients.
Mod Pathol. 2014 Nov;27(11):1430-1437. doi: 10.1038/modpathol.2014.51. Epub 2014 Apr 18.
10
The management of primary lymphoma of bone.
Radiother Oncol. 1987 Jun;9(2):137-45. doi: 10.1016/s0167-8140(87)80201-3.
本文引用的文献
1
Outcomes of limited stage primary bone diffuse large B-cell lymphoma in the rituximab era: a multicenter, retrospective study.
Haematologica. 2024 May 1;109(5):1439-1444. doi: 10.3324/haematol.2023.283210.
2
Positron Emission Tomography-Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001.
J Clin Oncol. 2020 Sep 10;38(26):3003-3011. doi: 10.1200/JCO.20.00999. Epub 2020 Jul 13.
3
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.
Lancet. 2019 Dec 21;394(10216):2271-2281. doi: 10.1016/S0140-6736(19)33008-9.
4
Outcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance.
Blood Adv. 2019 Oct 8;3(19):2804-2811. doi: 10.1182/bloodadvances.2019000458.
5
CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group.
Lancet Oncol. 2011 Oct;12(11):1013-22. doi: 10.1016/S1470-2045(11)70235-2. Epub 2011 Sep 21.
6
Early-stage Hodgkin's lymphoma.
N Engl J Med. 2010 Aug 12;363(7):653-62. doi: 10.1056/NEJMra1003733.
7
Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014.
J Clin Oncol. 2008 May 10;26(14):2258-63. doi: 10.1200/JCO.2007.13.6929. Epub 2008 Apr 14.
8
Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group study 1484.
J Clin Oncol. 2004 Aug 1;22(15):3032-8. doi: 10.1200/JCO.2004.06.088. Epub 2004 Jun 21.
9
Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma.
N Engl J Med. 1998 Jul 2;339(1):21-6. doi: 10.1056/NEJM199807023390104.
Zotero 插件